Partnership funds vital research into childhood leukaemia
Children’s Cancer and Leukaemia Group (CCLG) has partnered with the Harley Staples Cancer Trust (HSCT) to fund crucial new research into why leukaemia relapses.
What is the spleen and why does it matter if it receives radiotherapy?
Cancer treatments like radiotherapy can cause problems because they can harm healthy body cells as well as cancer cells. But what damage does it do and why does it matter?
CCLG survey reveals long-term impact of childhood cancer
A recent public survey undertaken by Children’s Cancer and Leukaemia Group (CCLG) has found that nearly 60% of childhood cancer survivors are faced with a range of health challenges, with the biggest impact on emotional and mental health.
CCLG Research Talks: What are the long term side effects of childhood cancer and its treatment?
Nicky Webb shares the long-term effects of childhood cancer and its treatments for Childhood Cancer Awareness Month.
Welcome to our new TYAC Chair and Executive member
We are delighted to welcome our new TYAC Chair Liz Purnell, Lead Nurse for Teenagers & Young Adults with Cancer for South Yorkshire, North Lincolnshire, and North Derbyshire, and Executive member Hanna Simpson, Lead Nurse for Teenagers & Young Adults with Cancer, Ambulatory Care and Withington Unit at The Christie NHS Foundation Trust.
Life after childhood cancer - what issues do survivors have to manage?
Cancer doesn't end when you finish treatment. Even after the cancer cells are long dead, the long-term effects of childhood cancer and its treatment remain. So, what are they?
Professor Jillian Mann, MBE: a tribute
Children’s Cancer and Leukaemia Group (CCLG) is deeply saddened to hear one of its founder members and pioneers in paediatric oncology, Professor Jillian Mann, MBE, has passed away, aged 84.
The 'glittering' idea that could help children with high-risk neuroblastoma
Children with aggressive neuroblastoma often can't be treated with standard treatments like radiotherapy and chemotherapy - but what about new treatments like immunotherapy?
Amelia's story
Amelia was originally diagnosed with Juvenile myelomonocytic leukemia (JMML) at 9 months old. Here she shares her story.